Gallant G - Search Results

1

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer.

Trarbach T, Moehler M, Heinemann V, Köhne CH, Przyborek M, Schulz C, Sneller V, Gallant G, Kanzler S. Trarbach T, et al. Among authors: gallant g. Br J Cancer. 2010 Feb 2;102(3):506-12. doi: 10.1038/sj.bjc.6605507. Epub 2010 Jan 12. Br J Cancer. 2010. PMID: 20068564 Free PMC article. Clinical Trial.

2

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer.

Greco FA, Bonomi P, Crawford J, Kelly K, Oh Y, Halpern W, Lo L, Gallant G, Klein J. Greco FA, et al. Among authors: gallant g. Lung Cancer. 2008 Jul;61(1):82-90. doi: 10.1016/j.lungcan.2007.12.011. Epub 2008 Feb 5. Lung Cancer. 2008. PMID: 18255187 Clinical Trial.

3

A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS).

Warner E, Goel R, Chang J, Chow W, Verma S, Dancey J, Franssen E, Dulude H, Girouard M, Correia J, Gallant G. Warner E, et al. Among authors: gallant g. Br J Cancer. 1998 Jun;77(12):2376-80. doi: 10.1038/bjc.1998.395. Br J Cancer. 1998. PMID: 9649162 Free PMC article. Clinical Trial.

4

Tumor Necrosis Factor-related apoptosis-inducing ligand (TRAIL) Receptor-1 and Receptor-2 agonists for cancer therapy.

Fox NL, Humphreys R, Luster TA, Klein J, Gallant G. Fox NL, et al. Among authors: gallant g. Expert Opin Biol Ther. 2010 Jan;10(1):1-18. doi: 10.1517/14712590903319656. Expert Opin Biol Ther. 2010. PMID: 19857186 Review.

5

Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.

Bow EJ, Gallant G, Williams GJ, Woloschuk D, Shore TB, Rubinger M, Schacter BA. Bow EJ, et al. Among authors: gallant g. Cancer. 1998 Oct 1;83(7):1344-54. Cancer. 1998. PMID: 9762935 Clinical Trial.

6

Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies.

Plummer R, Ghielmini M, Calvert P, Voi M, Renard J, Gallant G, Gupta E, Calvert H, Sessa C. Plummer R, et al. Among authors: gallant g. Clin Cancer Res. 2002 Sep;8(9):2788-97. Clin Cancer Res. 2002. PMID: 12231518 Clinical Trial.

7

A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer.

Glück S, Germond C, Lopez P, Cano P, Dorreen M, Koski T, Arnold A, Dulude H, Gallant G. Glück S, et al. Among authors: gallant g. Eur J Cancer. 1998 Jun;34(7):1008-14. doi: 10.1016/s0959-8049(97)10168-x. Eur J Cancer. 1998. PMID: 9849448 Clinical Trial.

8

Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 days.

Sun W, Stevenson JP, Gallagher ML, Vaughn D, Hahn SM, Haller DG, Cohen M, Kopit J, Gallant G, O'Dwyer PJ. Sun W, et al. Among authors: gallant g. Clin Cancer Res. 2003 Nov 1;9(14):5221-7. Clin Cancer Res. 2003. PMID: 14614002 Clinical Trial.

9

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

Ranson M, Davidson N, Nicolson M, Falk S, Carmichael J, Lopez P, Anderson H, Gustafson N, Jeynes A, Gallant G, Washington T, Thatcher N. Ranson M, et al. Among authors: gallant g. J Natl Cancer Inst. 2000 Jul 5;92(13):1074-80. doi: 10.1093/jnci/92.13.1074. J Natl Cancer Inst. 2000. PMID: 10880550 Clinical Trial.

10

Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.

Gatzemeier U, von Pawel J, Gottfried M, ten Velde GP, Mattson K, de Marinis F, Harper P, Salvati F, Robinet G, Lucenti A, Bogaerts J, Gallant G. Gatzemeier U, et al. Among authors: gallant g. J Clin Oncol. 2000 Oct 1;18(19):3390-9. doi: 10.1200/JCO.2000.18.19.3390. J Clin Oncol. 2000. PMID: 11013280 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page